Healthcare voice AI company Suki recently fleshed out its leadership team with six new appointments.
Chief among these are Tracy Rentz, former VP of implementation at Evolent Health, as Suki's VP of customer success and operations; former Qventus Regional Director Brian Duffy as Suki's director of Sales-East; and Brent Jarkowski, previously the senior client development director at Kyyrus, as director of Sales-West.
Other pickups included Josh Margulies as senior director of field marketing, Jon Niswander as VP of security and compliance, and Candice Tse as director of product.
“The timing of these new additions to Suki’s leadership team will be critical to support this period of commercial expansion as more physicians and health executives realize the value of Suki to save time, preserve revenue, and enable doctors to focus on what’s most important: the patient," Punit Soni, CEO and founder of Suki, said in a statement.
Connected ECG device and analysis company AliveCor announced this week the addition of former Cleveland Clinic CEO and president Dr. Toby Cosgrove to its board of directors. Cosgrove, a cardiac surgeon who performed more than 22,000 operations over the course of his career, lends the digital health company his insight on cardiology as well as clinical patient care and the patient experience.
“Over the course of my career, putting patients at the center of everything I do has been my guiding principle,” he said in a statement. “I am excited for the opportunity to further AliveCor’s mission of making heart care more accessible, affordable, and convenient. Their personal ECG technology paired with cutting-edge AI diagnostics is carving an entirely new space in digital health with the power to transform the quality, responsiveness, and cost of cardiac care worldwide.”
OptimizeRx, a software company that enables digital health messaging between pharmas, providers and patients, has added Angelo Campano to its team SVP and principal of agency channels. Previously the SVP for point of care marketing at Ogilvy Health, Campano will be looking to grow and expand his new company's partnerships with healthcare advertising agencies.
“Angelo is an incredibly well-respected thought leader, innovator and strategist in point-of-care solutions, and we are honored to have him join our team,” Steve Silvestro, chief commercial officer at OptimizeRx, said in a statement. “His proven ability to develop partnerships that bring digital touchpoints together at the point-of-care greatly complements our mission of helping life sciences be present throughout the care journey."
Cleo recently appointed Karin Ajmani to its board of directors at the beginning of October. Previously she served as the CEO of CarePlus Health Plans. Most recently, she served as president and chief strategy officer at Progyny, a national infertility health benefits company based in New York, where she was responsible for driving the company to over $150 million in revenue.
She currently serves on the board of directors for Caption Health, an AI-enabled cardiac imaging company, and SWORD, a digital musculoskeletal and pulmonary therapy provider.
London-based Proximie, a company that uses augmented reality to let surgeons remotely help their peers while operating, has named Paul Nendick as its next chief technology officer. Prior to joining Proximie, Nendick was the head of product development at ClearView Flex.
The company also announced that Jennifer Browning Holmes would step into the role of global chief commercial officer. She previously served as the SVP of corporate accounts at Proximo Medial, and as the CEO of Central Logic.
Lastly, Dr. Rajesh Aggarwal joined the team to advise on the U.S. health system and strategy. He is currently EVP of Jefferson Strategic Ventures and a professor at Thomas Jefferson University. “We’re thrilled by the expansion of our executive and advisory teams, at a time when our growth and market presence is spiking sharply. The future of health technology is hugely exciting,” Dr. Nadine Hachach-Haram, CEO and founder of Proximie said in a statement. “These appointments reflect our ambition to capture the market opportunity and meet growing demand.”